Short Interest in Fonar Corporation Rises By 61.3%

The medical equipment company saw a significant increase in short positions on its stock in January.

Published on Feb. 16, 2026

Got story updates? Submit your updates here. ›

Fonar Corporation (NASDAQ:FONR), a medical technology company that designs and manufactures MRI systems, experienced a 61.3% increase in short interest on its stock during the month of January. As of January 30th, there were 11,690 shares shorted, up from 7,246 shares on January 15th. This represents 0.2% of the company's total shares outstanding.

Why it matters

Changes in short interest can provide insights into investor sentiment and market expectations around a company's stock. The significant rise in short positions on Fonar suggests that some investors are betting against the stock's performance in the near-term, potentially due to concerns about the company's outlook or valuation.

The details

Fonar's stock opened at $18.55 on Monday, with a 50-day moving average of $17.34 and a 200-day average of $15.97. The company has a market cap of $115.01 million and a price-to-earnings ratio of 16.42. Fonar reported earnings of $0.31 per share in its most recent quarter, with revenue of $25.55 million.

  • As of January 30th, 2026, there was short interest totaling 11,690 shares of Fonar Corporation.
  • On January 15th, 2026, the short interest in Fonar was 7,246 shares.

The players

Fonar Corporation

A medical technology company primarily engaged in the design, manufacture and sale of magnetic resonance imaging (MRI) systems, including its flagship UPRIGHT® Multi-Position™ MRI product.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in short interest on Fonar's stock suggests that some investors are taking a bearish stance on the company's near-term prospects, potentially due to concerns about its financial performance or market positioning. However, the company's recent financial results and product offerings indicate it may still have growth potential.